Table 2.
Microbiological results
| Primary patients | Referred patients | p-value | ||
|---|---|---|---|---|
| Culture-positive/Total patients | 10/11 | 27/34 | 0.657 | |
| Mono/Polymicrobial | 10/0 | 20/7 | 0.155 | |
| Identified Organisms | 10 | 35 | ||
| Gram-positive cocci | MSSA | 8 | 1 | < 0.001 |
| MRSA | 0 | 14 | 0.006 | |
| Streptococcus species | 0 | 5 | 0.295 | |
| Enterococcus faecalis | 0 | 1 | 1.0 | |
| Gram-negative bacteria | Pseudomonas aeruginosa | 1 | 3 | 1.0 |
| Pasteurella species | 1 | 2 | 1.0 | |
| Eschericia coli | 0 | 2 | 1.0 | |
| Enterobacter cloacae | 0 | 2 | 1.0 | |
| Proteus vulgaris | 0 | 2 | 1.0 | |
| Prevotella species | 0 | 1 | 1.0 | |
| Aeromonas sobria | 0 | 1 | 1.0 | |
| Fungal infection | Candida parapsilosis | 0 | 1 | 1.0 |
| Susceptibility to cefazolin (yes/no) | 9/1 | 4/23 | < 0.001 | |
Significant values shown in bold
MRSA methicillin-resistant Staphylococcus aureus, MSSA methicillin-sensitive Staphylococcus aureus